Skip to content
healthcare.dev
Get a free key

UPLIZNA

NDC 75987-150, Inebilizumab, injection, from Horizon Therapeutics USA, Inc..

Product NDC
75987-150
Status
Listed
Labeler
Horizon Therapeutics USA, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761142
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75987-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INEBILIZUMAB10 mg/mL

Pharmacologic classes

CD19-directed Antibody Interactions [MoA]; CD19-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
75987-150-03759870150033 VIAL, SINGLE-DOSE in 1 CARTON (75987-150-03) / 10 mL in 1 VIAL, SINGLE-DOSE (75987-150-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/834db232-afb0-4dcf-93e0-009ce8245c20

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75987-150

Use it

Look up 75987-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75987-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75987-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.